Skip to main content
Premium Trial:

Request an Annual Quote

Gel Company, Weizmann Institute, University of Salzburg, Whitehead Institute, Institute for Systems Biology


The Gel Company of San Francisco has released ArrayBooster, a low-volume hybridization station for DNA and protein microarrays. The station, which uses technology based on surface acoustic waves to agitate the sample during the incubation process, is compatible with all microarrays in microscope slide format. Up to four instruments with 16 chambers in total can be controlled by one PC.


The Weizmann Institute has released SeqAlert, a sequence alerting service that periodically compares amino acid sequences of interest against sequences of proteins in the Protein Data Bank and TargetDB whose 3D structures have been determined or are being determined, at salertb/main.


An updated version of ProSup, a program for protein structure superimposition from the University of Salzburg in Austria, is available at


Version 1.1 of Cytoscape, visualization software to depict molecular interactions developed by researchers at the Whitehead Institute and the Institute for Systems Biology, is available at index.html.


The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.